a Children's National Heart Institute.
Am J Bioeth. 2016;16(1):11-7. doi: 10.1080/15265161.2015.1115140.
Critical congenital heart disease (CCHD) screening is rapidly becoming the standard of care in the United States after being added to the Recommended Uniform Screening Panel (RUSP) in 2011. Newborn screens typically do not require affirmative parental consent. In fact, most states allow parents to exempt their baby from receiving the required screen on the basis of religious or personally held beliefs. There are many ethical considerations implicated with allowing parents to exempt their child from newborn screening for CCHD. Considerations include the treatment of religious exemptions in our current legal system, as well as medical and ethical principles in relation to the rights of infants. Although there are significant benefits to screening newborns for CCHD, when a parent refuses for religious or personal beliefs, in the case of CCHD screening, the parental decision should stand.
先天性心脏病(CCHD)的筛查在美国已经成为标准的医疗护理,在 2011 年被添加到推荐的统一筛查面板(RUSP)之后。新生儿筛查通常不需要父母的明确同意。事实上,大多数州允许父母以宗教或个人信仰为由,豁免他们的孩子接受所需的筛查。允许父母豁免其孩子接受先天性心脏病新生儿筛查涉及到许多伦理问题。需要考虑的因素包括在我们现行法律体系中如何对待宗教豁免,以及与婴儿权利相关的医疗和伦理原则。尽管对新生儿进行 CCHD 筛查有显著的益处,但当父母出于宗教或个人信仰而拒绝时,在 CCHD 筛查的情况下,应尊重父母的决定。